QuidelOrtho Corp
Veridion Score
Composite trend over time
Why is QDEL moving today?
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for QDEL.
QDEL insider activity
QuidelOrtho Corp
No multi-insider buying cluster in the last 90 days
Net buying: $380K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | 2026-05-15 | Blaser Brian J. | Insider | sell | $10.32 | 10,252 | 35,649 | $106K | SEC Form 4 |
| 2026-04-28 | 2026-04-26 | McLellan Philip D. | Insider | sell | $11.59 | 699 | 22,497 | $8K | SEC Form 4 |
| 2026-04-28 | 2026-04-26 | Hanson Bryan Michael | Insider | sell | $11.59 | 528 | 4,070 | $6K | SEC Form 4 |
| 2026-04-24 | 2026-04-22 | Hanson Bryan Michael | Insider | sell | $11.90 | 1,269 | 3,139 | $15K | SEC Form 4 |
| 2026-04-24 | 2026-04-22 | McLellan Philip D. | Insider | sell | $11.90 | 1,162 | 21,250 | $14K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 31 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moQDEL contract awards, year to date.
Public federal awards linked to this ticker.
QDEL lobbying filings, year to date.
Registered lobbying filings matched to QuidelOrtho Corp.